Cempra Inc (CEMP.OQ) Quote| Reuters.com
Edition:
United States

Cempra Inc (CEMP.OQ)

CEMP.OQ on NASDAQ Stock Exchange Global Select Market

17.41USD
24 Jun 2016
Change (% chg)

$-1.15 (-6.20%)
Prev Close
$18.56
Open
$17.44
Day's High
$18.29
Day's Low
$17.15
Volume
744,673
Avg. Vol
214,630
52-wk High
$46.97
52-wk Low
$14.05

CEMP.OQ

Chart for CEMP.OQ

About

Cempra, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing differentiated antibiotics for the acute care and community settings to meet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic staphylococcal infections. The Company's... (more)

Overall

Beta: 1.31
Market Cap(Mil.): $839.17
Shares Outstanding(Mil.): 48.20
Dividend: --
Yield (%): --

Financials

  CEMP.OQ Industry Sector
P/E (TTM): -- 38.82 34.11
EPS (TTM): -2.10 -- --
ROI: -49.22 -5.72 14.23
ROE: -55.87 -4.83 15.46

U.S. RESEARCH ROUNDUP-T-Mobile, Weatherford International, Extra Space Storage

June 24 Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CubeSmart, Sovran Self Storage and CACI International, on Friday. HIGHLIGHTS * T-Mobile US Inc : Nomura cuts to neutral from buy * Weatherford International Plc : Imperial Capital starts with an in-line rating * Extra Space Storage , Sovran Self Storage :DA Davidson starts with neutral

Jun 24 2016

BRIEF-Cempra announces positive data from Japenese study on solithromycin

* Cempra announces successful results in the phase 2 community acquired bacterial pneumonia (cabp) trial conducted by japanese partner, toyama chemical (a subsidiary of fujifilm holdings corporation) Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)

May 25 2016

BRIEF-Levin Capital Strategies reports 5.6 pct passive stake in Cempra

* Levin Capital Strategies L.P. reports 5.6 pct passive stake in Cempra - SEC filing Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Apr 01 2016

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,496 -117.00
Johnson & Johnson (JNJ.N) $115.63 -1.75
Pfizer Inc. (PFE.N) $33.97 -0.62
Roche Holding Ltd. (ROG.S) CHF241.00 -5.50
Roche Holding Ltd. (RO.S) CHF246.20 -3.30
Abbott Laboratories (ABT.N) $37.91 -1.72
Bayer AG (BAYGn.DE) €87.64 -5.53
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €69.37 -2.63
AstraZeneca plc (AZN.L) 4,031.50p +133.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Jefferson Research
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.